Building on Sociological Understandings of the Pharmaceutical Industry or Reinventing the Wheel? Response to Joan Busfield's `Pills,Power,People'

Abraham, J. (1993) `Scientific Standards and Institutional Interests: Carcinogenic Risk Assessment of Benoxaprofen in the UK and the US', Social Studies of Science 23: 387—444.

Abraham, J. (1994) `Bias in Science and Medical Knowledge: The Opren Controversy', Sociology 28: 717—36.

Abraham, J. (1995a) Science, Politics and the Pharmaceutical Industry London: UCL Press.

Abraham, J. (1995b) `The Production and Reception of Scientific Papers in the Academic-Industrial Complex: The Clinical Evaluation of New Medicines' , British Journal of Sociology 46: 167—90.

Abraham, J. (1997) `The Science and Politics of Medicines Regulation ', in M.A. Elston (ed.) Sociology of Health & Illness Special Monograph Issue on the Sociology of Medical Science and Technology, pp. 153—82. Oxford : Blackwell.

Abraham, J. (2002a) `Transnational Industrial Power, the Medical Profession and the Regulatory State', Social Science & Medicine 55: 1671—90.

Abraham, J. (2002b) `The Pharmaceutical Industry as Political Player' , Lancet 360: 1498—502.

Abraham, J. and C. Davis (2005) `A Comparative Analysis of Drug Safety Withdrawals in the UK and the US (1971—1992): Implications for Current Regulatory Thinking and Policy', Social Science & Medicine 61: 881—92.

Abraham, J. and T. Reed (2001) `Trading Risks for Markets: The International Harmonisation of Pharmaceutical Regulation', Health, Risk & Society: Special Issue on Globalisation 3: 113—28.

Abraham, J. and T. Reed (2003) `Globalization of Medicines Control', in J. Abraham and H. Lawton Smith (eds) Regulation of the Pharmaceutical Industry, pp. 82—107. Basingstoke: Palgrave.

Abraham, J. and J. Sheppard (1998) `International Comparative Analysis and Explanation in Medical Sociology: Demystifying the Halcion Anomaly', Sociology 32: 141—62.

Abraham, J. and J. Sheppard (1999) `Complacent and Conflicting Scientific Expertise in British and American Drug Regulation', Social Studies of Science 29: 803—44.

Bowe, C. (2004) `FDA Official Warns on more Drugs in Hearing', Financial Times 19 November.

Braithwaite, J. (1984) Corporate Crime in the Pharmaceutical Industry . London: Routledge.

Braithwaite, J. and P. Drahos (2000) Global Business Regulation. Cambridge: Cambridge University Press.

Bury, M. and J. Gabe (1996) `Halcion Nights: A Sociological Account of a Medical Controversy', Sociology 30: 447—69.

Busfield, J. (2006) `Pills, Power, People: Sociological Understandings of the Pharmaceutical Industry', Sociology 40: 297—314.

Daemmrich, A. (2004) Pharmacopolitics: Drug Regulation in the US and Germany. Chapel Hill: University of North Carolina Press.

Epstein, S. (1996) Impure Science: AIDS, Activism and the Politics of Knowledge Berkeley: University of California Press.

Gabe, J. and M. Bury (1996) `Anxious Times: The Benzodiazepine Controversy and the Fracturing of Expert Authority', in P. Davis (ed.) Contested Ground: Public Purpose and Private Interest in the Regulation of Prescription Drugs, pp. 42—56. New York: Oxford University Press.

Gijswijt-Hofstra, M. , G.M. Van Hetren and E.M. Tansey (eds) (2002) Biographies of Remedies: Drugs, Medicines and Contraceptives in Dutch and Anglo-American Healing Cultures. Amsterdam : Rodopi.

Hedgecoe, A. and P. Martin (2003) `The Drugs Don't Work', Social Studies of Science 33: 327—64.

House of Commons (2005) The Influence of the Pharmaceutical Industry. Health Committee — Fourth Report of Session 2004—5, Vol. 1.

Lakoff, A. (2004) `The Anxieties of Globalisation: Antidepressant Sales and Economic Crisis in Argentina', Social Studies of Science 34: 247—70.

Latour, B. (1987) Science in Action. Cambridge, MA: Harvard University Press.

Liebenau, J. (1987) Medical Science and Medical Industry. Baltimore, MD: Johns Hopkins University Press.

Marks, L. (1997) The Progress of Experiment: Science and Therapeutic Reform in the US, 1900—1990. Cambridge: Cambridge University Press.

Pieters, T. (2004) `Hailing a Miracle Drug: The Interferon', in W. de Blecourt and C. Usborne (eds) Cultural Approaches to the History of Medicine , pp. 212—32. Basingstoke: Palgrave .

Rasmussen, N. (2004) `The Moral Economy of the Drug Company—Medical Scientist Collaboration in Interwar America', Social Studies of Science 34: 161—86.

Swann, J.P. (1988) Academic Scientists and the Pharmaceutical Industry . Baltimore, MD: Johns Hopkins University Press.

Timmermans, K. (2004) `Harmonization, Regulation and Trade: Intersections in the Pharmaceutical Field', International Journal of Health Services 34: 651—61.

Vos, R. ( 1991) Drugs Looking for Diseases. Dordrecht : Kluwer.